Two different binding modes of α-synuclein to lipid vesicles depending on its aggregation state

Biophysical Journal

Volumn 102, Issue 7, 2012, Pages 1646-1655

  Högen, Tobias ^a   Levin, Johannes ^a   Schmidt, Felix ^b   Caruana, Mario ^c   Vassallo, Neville ^c   Kretzschmar, Hans ^b   Bötzel, Kai ^a   Kamp, Frits ^b   Giese, Armin ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MALTA   (Malta)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DIMETHYL SULFOXIDE; LIPOSOME; PHOSPHOLIPID;

ARTICLE; CELL MEMBRANE; CHEMISTRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; METABOLISM; METHODOLOGY; PARKINSON DISEASE; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; SPECTROFLUOROMETRY;

ALPHA-SYNUCLEIN; CELL MEMBRANE; DIMETHYL SULFOXIDE; FLUORESCENCE RESONANCE ENERGY TRANSFER; PARKINSON DISEASE; PHOSPHOLIPIDS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; SPECTROMETRY, FLUORESCENCE; UNILAMELLAR LIPOSOMES;

EID: 84859386811     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2012.01.059     Document Type: Article

References (89)

1. E.H. Koo, P.T. Lansbury Jr., and J.W. Kelly Amyloid diseases: abnormal protein aggregation in neurodegeneration Proc. Natl. Acad. Sci. USA 96 1999 9989 9990
2. C.M. Dobson Protein folding and misfolding Nature 426 2003 884 890
3. I. Kuperstein, and K. Broersen B. De Strooper Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio EMBO J. 29 2010 3408 3420
4. M. Kostka, and T. Högen A. Giese Single particle characterization of iron-induced pore-forming α-synuclein oligomers J. Biol. Chem. 283 2008 10992 11003
5. K. Beyer Mechanistic aspects of Parkinson's disease: α-synuclein and the biomembrane Cell Biochem. Biophys. 47 2007 285 299
6. C. Haass, and D.J. Selkoe Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide Nat. Rev. Mol. Cell Biol. 8 2007 101 112
7. R. Kayed, and Y. Sokolov C.G. Glabe Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases J. Biol. Chem. 279 2004 46363 46366
8. M. Bucciantini, and E. Giannoni M. Stefani Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 2002 507 511
9. M.G. Spillantini, and M.L. Schmidt M. Goedert α-synuclein in Lewy bodies Nature 388 1997 839 840
10. A. Iwai, and E. Masliah T. Saitoh The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system Neuron 14 1995 467 475
11. T. Bartels, and L.S. Ahlstrom K. Beyer The N-terminus of the intrinsically disordered protein α-synuclein triggers membrane binding and helix folding Biophys. J. 99 2010 2116 2124
12. L.A. Munishkina, and C. Phelan A.L. Fink Conformational behavior and aggregation of α-synuclein in organic solvents: modeling the effects of membranes Biochemistry 42 2003 2720 2730
13. A. Santner, and V.N. Uversky Metalloproteomics and metal toxicology of α-synuclein Metallomics 2 2010 378 392
14. V.N. Uversky Neuropathology, biochemistry, and biophysics of α-synuclein aggregation J. Neurochem. 103 2007 17 37
15. D.P. Karpinar, and M.B. Balija M. Zweckstetter Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models EMBO J. 28 2009 3256 3268
16. K.K. Dev, and K. Hofele H. van der Putten Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease Neuropharmacology 45 2003 14 44
17. T. Nonaka, and S.T. Watanabe M. Hasegawa Seeded aggregation and toxicity of α-synuclein and tau: cellular models of neurodegenerative diseases J. Biol. Chem. 285 2010 34885 34898
18. C.G. Glabe Structural classification of toxic amyloid oligomers J. Biol. Chem. 283 2008 29639 29643
19. C.G. Glabe, and R. Kayed Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis Neurology 66 2006 S74 S78
20. M.J. Volles, and P.T. Lansbury Jr. Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism Biochemistry 41 2002 4595 4602
21. B. Caughey, and P.T. Lansbury Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders Annu. Rev. Neurosci. 26 2003 267 298
22. B.D. van Rooijen, M.M. Claessens, and V. Subramaniam Membrane binding of oligomeric α-synuclein depends on bilayer charge and packing FEBS Lett. 582 2008 3788 3792
23. B.D. van Rooijen, M.M. Claessens, and V. Subramaniam Lipid bilayer disruption by oligomeric α-synuclein depends on bilayer charge and accessibility of the hydrophobic core Biochim. Biophys. Acta 1788 2009 1271 1278
24. V.N. Uversky, J. Li, and A.L. Fink Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure J. Biol. Chem. 276 2001 44284 44296
25. A. Binolfi, and R.M. Rasia C.O. Fernández Interaction of α-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement J. Am. Chem. Soc. 128 2006 9893 9901
26. Y. Peng, and C. Wang F. Zhou Binding of α-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes J. Inorg. Biochem. 104 2010 365 370
27. P. Davies, D. Moualla, and D.R. Brown α-synuclein is a cellular ferrireductase PLoS ONE 6 2011 e15814
28. J. Zayed, and S. Ducic M. Roy Environmental factors in the etiology of Parkinson's disease Can. J. Neurol. Sci. 17 1990 286 291
29. G. Logroscino, and X. Gao A. Ascherio Dietary iron intake and risk of Parkinson's disease Am. J. Epidemiol. 168 2008 1381 1388
30. M.E. Götz, and K. Double P. Riederer The relevance of iron in the pathogenesis of Parkinson's disease Ann. N. Y. Acad. Sci. 1012 2004 193 208
31. A. Gaeta, and R.C. Hider The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy Br. J. Pharmacol. 146 2005 1041 1059
32. W.S. Davidson, and A. Jonas J.M. George Stabilization of α-synuclein secondary structure upon binding to synthetic membranes J. Biol. Chem. 273 1998 9443 9449
33. F. Kamp, and K. Beyer Binding of α-synuclein affects the lipid packing in bilayers of small vesicles J. Biol. Chem. 281 2006 9251 9259
34. B. Nuscher, and F. Kamp K. Beyer α-synuclein has a high affinity for packing defects in a bilayer membrane: a thermodynamics study J. Biol. Chem. 279 2004 21966 21975
35. M. Drescher, and F. Godschalk M. Huber Spin-label EPR on α-synuclein reveals differences in the membrane binding affinity of the two antiparallel helices ChemBioChem 9 2008 2411 2416
36. M. Drescher, and G. Veldhuis M. Huber Antiparallel arrangement of the helices of vesicle-bound α-synuclein J. Am. Chem. Soc. 130 2008 7796 7797
37. T.S. Ulmer, and A. Bax R.L. Nussbaum Structure and dynamics of micelle-bound human α-synuclein J. Biol. Chem. 280 2005 9595 9603
38. A.C. Ferreon, and Y. Gambin A.A. Deniz Interplay of α-synuclein binding and conformational switching probed by single-molecule fluorescence Proc. Natl. Acad. Sci. USA 106 2009 5645 5650
39. S. Kubo, and V.M. Nemani D.L. Fortin A combinatorial code for the interaction of α-synuclein with membranes J. Biol. Chem. 280 2005 31664 31672
40. E.R. Middleton, and E. Rhoades Effects of curvature and composition on α-synuclein binding to lipid vesicles Biophys. J. 99 2010 2279 2288
41. V.V. Shvadchak, and L.J. Falomir-Lockhart T.M. Jovin Specificity and kinetics of α-synuclein binding to model membranes determined with fluorescent excited state intramolecular proton transfer (ESIPT) probe J. Biol. Chem. 286 2011 13023 13032
42. 2H NMR spectroscopy J. Am. Chem. Soc. 130 2008 14521 14532
43. V. Narayanan, and S. Scarlata Membrane binding and self-association of α-synucleins Biochemistry 40 2001 9927 9934
44. E. Rhoades, and T.F. Ramlall D. Eliezer Quantification of α-synuclein binding to lipid vesicles using fluorescence correlation spectroscopy Biophys. J. 90 2006 4692 4700
45. F. Kamp, and N. Exner C. Haass Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1 EMBO J. 29 2010 3571 3589
46. V.M. Nemani, and W. Lu R.H. Edwards Increased expression of α-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis Neuron 65 2010 66 79
47. D.A. Scott, and I. Tabarean S. Roy A pathologic cascade leading to synaptic dysfunction in α-synuclein-induced neurodegeneration J. Neurosci. 30 2010 8083 8095
48. J. Burré, and M. Sharma T.C. Südhof α-synuclein promotes SNARE-complex assembly in vivo and in vitro Science 329 2010 1663 1667
49. K. Nakamura, and V.M. Nemani R.H. Edwards Optical reporters for the conformation of α-synuclein reveal a specific interaction with mitochondria J. Neurosci. 28 2008 12305 12317
50. M.S. Parihar, and A. Parihar P. Ghafourifar Mitochondrial association of α-synuclein causes oxidative stress Cell. Mol. Life Sci. 65 2008 1272 1284
51. C. Behrends, and C.A. Langer F.U. Hartl Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers Mol. Cell 23 2006 887 897
52. J. Bieschke, and A. Giese H. Kretzschmar Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets Proc. Natl. Acad. Sci. USA 97 2000 5468 5473
53. A. Giese, and J. Levin H. Kretzschmar Effect of metal ions on de novo aggregation of full-length prion protein Biochem. Biophys. Res. Commun. 320 2004 1240 1246
54. J. Levin, and U. Bertsch A. Giese Single particle analysis of manganese-induced prion protein aggregates Biochem. Biophys. Res. Commun. 329 2005 1200 1207
55. P. Kask, and K. Palo K. Gall Fluorescence-intensity distribution analysis and its application in biomolecular detection technology Proc. Natl. Acad. Sci. USA 96 1999 13756 13761
56. A. Giese, and B. Bader H. Kretzschmar Single particle detection and characterization of synuclein co-aggregation Biochem. Biophys. Res. Commun. 333 2005 1202 1210
57. S. Hüls, and T. Högen J. Herms AMPA-receptor-mediated excitatory synaptic transmission is enhanced by iron-induced α-synuclein oligomers J. Neurochem. 117 2011 868 878
58. D. Berg, and M. Gerlach G. Becker Brain iron pathways and their relevance to Parkinson's disease J. Neurochem. 79 2001 225 236
59. P. Riederer, and E. Sofic M.B. Youdim Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains J. Neurochem. 52 1989 515 520
60. F. Kamp, and J.A. Hamilton J.A. Hamilton Movement of fatty acids, fatty acid analogues, and bile acids across phospholipid bilayers Biochemistry 32 1993 11074 11086
61. V.N. Uversky, and H.J. Lee S.J. Lee Stabilization of partially folded conformation during α-synuclein oligomerization in both purified and cytosolic preparations J. Biol. Chem. 276 2001 43495 43498
62. E.A. Jares-Erijman, and T.M. Jovin FRET imaging Nat. Biotechnol. 21 2003 1387 1395
63. P.J. Kahle, and M. Neumann C. Haass Selective insolubility of α-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model Am. J. Pathol. 159 2001 2215 2225
64. R. Sharon, and I. Bar-Joseph D.J. Selkoe The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinson's disease Neuron 37 2003 583 595
65. N.W. Schiffer, and S.A. Broadley B. Schmid Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model J. Biol. Chem. 282 2007 9195 9203
66. J. Bieschke, and J. Russ E.E. Wanker EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity Proc. Natl. Acad. Sci. USA 107 2010 7710 7715
67. M. Masuda, and N. Suzuki M. Hasegawa Small molecule inhibitors of α-synuclein filament assembly Biochemistry 45 2006 6085 6094
68. U. Bertsch, and K.F. Winklhofer A. Giese Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets J. Virol. 79 2005 7785 7791
69. M. Zhu, and S. Rajamani A.L. Fink The flavonoid baicalein inhibits fibrillation of α-synuclein and disaggregates existing fibrils J. Biol. Chem. 279 2004 26846 26857
70. M. Caruana, and T. Högen N. Vassallo Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds FEBS Lett. 585 2011 1113 1120
71. A.S. Hillmer, and P. Putcha A. Giese Converse modulation of toxic α-synuclein oligomers in living cells by N′-benzylidene- benzohydrazide derivates and ferric iron Biochem. Biophys. Res. Commun. 391 2010 461 466
72. M. Necula, and R. Kayed C.G. Glabe Small molecule inhibitors of aggregation indicate that amyloid β oligomerization and fibrilization pathways are independent and distinct J. Biol. Chem. 282 2007 10311 10324
73. J. Wang, and L. Ho G.M. Pasinetti Grape-derived polyphenolics prevent Aβ oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease J. Neurosci. 28 2008 6388 6392
74. R. Kayed, and A. Pensalfini C. Glabe Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer J. Biol. Chem. 284 2009 4230 4237
75. M. Cisse, and B. Halabisky L. Mucke Reversing EphB2 depletion rescues cognitive functions in Alzheimer model Nature 469 2011 47 52
76. U.K. Resenberger, and A. Harmeier J. Tatzelt The cellular prion protein mediates neurotoxic signaling of β-sheet-rich conformers independent of prion replication EMBO J. 30 2011 2057 2070
77. S. Li, and M. Jin D.J. Selkoe Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors J. Neurosci. 31 2011 6627 6638
78. B.L. Kagan, and Y. Hirakura M.C. Lin The channel hypothesis of Alzheimer's disease: current status Peptides 23 2002 1311 1315
79. H.Y. Kim, and M.K. Cho M. Zweckstetter Structural properties of pore-forming oligomers of α-synuclein J. Am. Chem. Soc. 131 2009 17482 17489
80. B.D. van Rooijen, M.M. Claessens, and V. Subramaniam Membrane permeabilization by oligomeric α-synuclein: in search of the mechanism PLoS ONE 5 2010 e14292
81. D.P. Smith, and D.J. Tew R. Cappai Formation of a high affinity lipid-binding intermediate during the early aggregation phase of α-synuclein Biochemistry 47 2008 1425 1434
82. D.A. Bosco, and D.M. Fowler J.W. Kelly Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate α-synuclein fibrilization Nat. Chem. Biol. 2 2006 249 253
83. M. Necula, C.N. Chirita, and J. Kuret Rapid anionic micelle-mediated α-synuclein fibrilization in vitro J. Biol. Chem. 278 2003 46674 46680
84. R.J. Perrin, and W.S. Woods J.M. George Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins J. Biol. Chem. 276 2001 41958 41962
85. J. Pronchik, and X. He D.S. Talaga In vitro formation of amyloid from α-synuclein is dominated by reactions at hydrophobic interfaces J. Am. Chem. Soc. 132 2010 9797 9803
86. A.P. Pandey, and F. Haque J.S. Hovis Clustering of α-synuclein on supported lipid bilayers: role of anionic lipid, protein, and divalent ion concentration Biophys. J. 96 2009 540 551
87. M. Drescher, and B.D. van Rooijen M. Huber A stable lipid-induced aggregate of α-synuclein J. Am. Chem. Soc. 132 2010 4080 4082
88. C.R. Bodner, and A.S. Maltsev A. Bax Differential phospholipid binding of α-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy Biochemistry 49 2010 862 871
89. L.A. Munishkina, A.L. Fink, and V.N. Uversky Conformational prerequisites for formation of amyloid fibrils from histones J. Mol. Biol. 342 2004 1305 1324